Baader Bank Aktiengesellschaft Zai Lab LTD Transaction History

Baader Bank Aktiengesellschaft

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$22.97 - $30.58 $213,253 - $283,904	9,284 New	9,284 $253,000
Q2 2023 Aug 11, 2023	BUY	$25.3 - $39.67 $34,408 - $53,951	1,360 Added 19.99%	8,162 $226,000
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $18,126 - $28,860	600 Added 9.67%	6,802 $226,000
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $138,180 - $240,079	6,202 New	6,202 $190,000
Q1 2022 May 18, 2022	SELL	$27.77 - $64.4 $186,114 - $431,608	-6,702 Closed	0 $0
Q4 2021 May 17, 2022	BUY	$54.9 - $105.21 $367,939 - $705,117	6,702 New	6,702 $421,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.